Ricky Goldwasser
Stock Analyst at Morgan Stanley
(2.3)
# 777
Out of 5,328 analysts
338
Total ratings
56.33%
Success rate
24.01%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DOCS Doximity | Maintains: Equal-Weight | 71 60 | 58.62 | 2.35% | 10 | Apr 24, 2025 | |
UNH UnitedHealth Group | Maintains: Overweight | 664 563 | 402.4 | 39.91% | 16 | Apr 22, 2025 | |
CRL Charles River | Maintains: Equal-Weight | 220 184 | 117.5 | 56.6% | 20 | Feb 5, 2025 | |
LH Labcorp Holdings | Maintains: Overweight | 260 270 | 241.55 | 11.78% | 15 | Dec 17, 2024 | |
ACCD Accolade | Maintains: Equal-Weight | 6 5 | n/a | n/a | 17 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 6.57 | 52.21% | 8 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 6 | 4.69 | 17.27% | 9 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 8 | 13.11 | -42.79% | 6 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 160 8 | n/a | n/a | 10 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 12 | 16.87 | -28.87% | 8 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 94 73 | 59.77 | 22.13% | 10 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 145 145 | 178.08 | -18.58% | 17 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 176 190 | n/a | n/a | 19 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 365 365 | 315.52 | 15.68% | 7 | Jul 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 403 420 | 709.53 | -40.81% | 22 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 120 | 6.64 | 1707.23% | 7 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 10 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 549 620 | 258.38 | 139.96% | 11 | Oct 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 18 | n/a | n/a | 6 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 485 500 | 411.21 | 21.59% | 2 | Oct 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 127 124 | 69.95 | 77.27% | 9 | Oct 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 296 318 | 336.05 | -5.37% | 11 | Aug 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 74 70 | 145.88 | -52.02% | 16 | Jul 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 43 39 | 10.94 | 256.49% | 14 | Jul 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 607 533 | n/a | n/a | 9 | Jun 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 24 14 | n/a | n/a | 6 | Feb 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 85 95 | n/a | n/a | 11 | Dec 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 25 | 30.84 | -18.94% | 1 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 115 135 | n/a | n/a | 8 | Feb 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 14 18 | n/a | n/a | 6 | Jan 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 182 195 | 152 | 28.29% | 6 | Oct 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 89 91 | n/a | n/a | 6 | Jul 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 128 135 | n/a | n/a | 3 | Dec 3, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 96 121 | n/a | n/a | 1 | Nov 9, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | n/a | n/a | n/a | 1 | May 11, 2017 |